Literature DB >> 3262243

Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis.

R J Shaw1, C Roussak, S M Forster, J R Harris, A J Pinching, D M Mitchell.   

Abstract

Pulmonary function was measured in 169 male patients seropositive for the human immunodeficiency virus (HIV). The transfer factor for carbon monoxide (TLCO) in symptom free patients and patients with persistent generalised lymphadenopathy was normal (greater than 83% of predicted values). Patients with the AIDS related complex, non-pulmonary Kaposi sarcoma, and non-pulmonary non-Kaposi sarcoma AIDS (that is, opportunist infections affecting other organs) had lower mean values for TLCO (77%, 70%, and 70% of predicted respectively). These values were significantly lower than values for symptom free patients. Lower mean values of 50% and 63% predicted TLCO were observed in patients during the acute and recovery phases of Pneumocystis carinii pneumonia. TLCO was also low in patients with lung mycobacterial infection and in a patient with lung Kaposi sarcoma. Forced expiratory volume in one second, peak expiratory flow, and maximal expiratory flow at 50% of vital capacity were significantly reduced only in patients with acute pneumocystis pneumonia. This study shows that abnormalities in the results of pulmonary function tests, particularly TLCO, although greatest in patients with pulmonary complications of AIDS, are also present in patients with AIDS but without other evidence of pulmonary disease, and in patients with the AIDS related complex. The predictive and prognostic implications of these findings require further investigation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262243      PMCID: PMC461306          DOI: 10.1136/thx.43.6.436

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome.

Authors:  D E Stover; D A White; P A Romano; R A Gellene; W A Robeson
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

2.  NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop.

Authors:  J F Murray; S M Garay; P C Hopewell; J Mills; G L Snider; D E Stover
Journal:  Am Rev Respir Dis       Date:  1987-02

3.  Role of fibreoptic bronchoscopy in management of pneumonia in acquired immune deficiency syndrome.

Authors:  J B Warren; R J Shaw; J N Weber; D A Holt; E E Keal; A J Pinching
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

4.  Pulmonary involvement in the acquired immunodeficiency syndrome.

Authors:  P C Hopewell; J M Luce
Journal:  Chest       Date:  1985-01       Impact factor: 9.410

5.  Human T lymphotropic virus type III infection of human alveolar macrophages.

Authors:  S Z Salahuddin; R M Rose; J E Groopman; P D Markham; R C Gallo
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

6.  Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

Authors:  J A Kovacs; J W Hiemenz; A M Macher; D Stover; H W Murray; J Shelhamer; H C Lane; C Urmacher; C Honig; D L Longo
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

7.  Correlation between serial pulmonary function tests and fiberoptic bronchoscopy in patients with Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome.

Authors:  D L Coleman; P M Dodek; J A Golden; J M Luce; E Golden; W M Gold; J F Murray
Journal:  Am Rev Respir Dis       Date:  1984-03

8.  Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities.

Authors:  E S Overland; A J Nolan; P C Hopewell
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

9.  Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome.

Authors:  A F Suffredini; F P Ognibene; E E Lack; J T Simmons; M Brenner; V J Gill; H C Lane; A S Fauci; J E Parrillo; H Masur
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

10.  Clinical features of Pneumocystis pneumonia in the acquired immune deficiency syndrome.

Authors:  L A Engelberg; C W Lerner; M L Tapper
Journal:  Am Rev Respir Dis       Date:  1984-10
View more
  21 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 2.  AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

Authors:  A B Millar; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

3.  Diagnosis of PCP in HIV seropositive patients.

Authors:  C J Skinner; R J Coker; D M Mitchell
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 4.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  HIV and chronic obstructive pulmonary disease: is it worse and why?

Authors:  Alison Morris; M Patricia George; Kristina Crothers; Laurence Huang; Lorrie Lucht; Cathy Kessinger; Eric C Kleerup
Journal:  Proc Am Thorac Soc       Date:  2011-06

6.  Contributors to diffusion impairment in HIV-infected persons.

Authors:  Matthew R Gingo; Jiayan He; Catherine Wittman; Carl Fuhrman; Joseph K Leader; Cathy Kessinger; Lorrie Lucht; William A Slivka; Yingze Zhang; Deborah K McMahon; Frank C Sciurba; Alison Morris
Journal:  Eur Respir J       Date:  2013-02-21       Impact factor: 16.671

7.  Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients.

Authors:  J R Clarke; I K Taylor; J Fleming; J D Williamson; D M Mitchell
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

8.  Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.

Authors:  R B Nieman; J Fleming; R J Coker; J R Harris; D M Mitchell
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

9.  Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study.

Authors:  Qu Cui; Sue Carruthers; Andrew McIvor; Fiona Smaill; Lehana Thabane; Marek Smieja
Journal:  AIDS Res Ther       Date:  2010-03-19       Impact factor: 2.250

Review 10.  Human immunodeficiency virus-associated obstructive lung diseases.

Authors:  Matthew R Gingo; Alison Morris; Kristina Crothers
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.